Formulation and Clinical Evaluation Of Ultradeformable Liposomes in the Topical Treatment of Psoriasis

REFERENCES

• Andrew LB, Richare AB, Jeffrey WH, Mark PL. Emerging therapeutic targets in psoriasis. Curr Opin Pharmacol. 2004; 4: 306–310
   PubMed Web of Science ®Google Scholar
• Linden KG, Gerald DW. Psoriasis: current perspective with an emphasis on treatment. Am J Med. 1999; 107: 595–605
   PubMed Web of Science ®Google Scholar
• Mendonca CO, Burden AD. Current concepts in psoriasis and treatment. Pharmacol Ther. 2003; 99: 133–137
   PubMed Web of Science ®Google Scholar
• David LM, Douglas GR, Eric AM, Carl DN. Systemic aspects of psoriasis: an integrative model based on intestinal etiology. Integr Med. 1999; 2(2/3)105–113
   Google Scholar
• Frank CS, Alan MM. Methotrexate and psoriasis in the era of new biologic agents. J Am Acad Dermatol. Feb, 2004; 50(2)301–309
   PubMed Web of Science ®Google Scholar
• Alvarez-Figueroa MJ, Blanco-Mendez J. Transdermal delivery of methotrexate: iontophoretic delivery from hydrogels and passive delivery from microemulsions. Int J Pharm. 2001; 215: 57–65
   PubMed Web of Science ®Google Scholar
• Alvarez-Figueroa MJ, Delgado-Charro MB, Blance-Mendez J. Passive and iontophoretic transdermal penetration of methotrexate. Int J Pharm. 2001; 212: 101–107
   PubMed Web of Science ®Google Scholar
• Trotta M, Pattarino F, Gasco FR. Influence of counterions on the skin permeation of methotrexate from water-oil microemulsions. Pharm Acta Hel. 1996; 71: 135–140
   PubMedGoogle Scholar
• Elisie O, Sandip BT, Udupa N, Ravindra K, UmaDevi P. Niosome entrapped B-cyclodextrin methotrexate complex as a drug delivery system. Ind J Pharmacol. 1999; 31: 279–284
   Google Scholar
• Guangwei L, Won JH. Diffusion studies of methotrexate in carbopol and poloxamer gels. Int J Pharm. 1998; 16: 1–9
   Google Scholar
• Trotta M, Peira E, Carlotti ME, Gallarate M. Deformable liposomes for dermal administration of methotrexate. Int J Pharm. 2004; 270: 119–115
   PubMed Web of Science ®Google Scholar
• Schmid MH, Korting HC. Therapeutic progress with topical liposome drugs for skin disease. Adv Drug Del Rev. 1996; 18: 335–342
   Web of Science ®Google Scholar
• Cevc G, Gabriele B. Biological activity and characteristics of triamcinolone-acetonide formulated with the self-regulation drug carriers, Transfersomes?. Biochim Biophys Acta. 2003; 1614: 156–164
   PubMed Web of Science ®Google Scholar
• Cevc G, Gabriele B. New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carrier, Transfersomes?. Biochim Biophys Acta. 2001; 1514: 191–205
   PubMed Web of Science ®Google Scholar
• Prasad VG, Peter AC, Ram BM. Gas chromatographic determination of residual levels of tert.-butanol from lyophilized liposomal formulations. J Chrom: Biomedical Appli. 1993; 620(1)83–88
   PubMed Web of Science ®Google Scholar
• Lee CR, Dau NV, Krstulovic M. Artefact formation in the determination of residual solvents according to a method of the European Pharmacopeia. Int J Pharm. 2000; 195: 159–169
   PubMedGoogle Scholar
• Coran SA, Giannellini V, Furlanetto S, Alberti MB, Pinzauti S. Improving gas chromatographic determination of residual solvents in pharmaceuticals by the combined use of headspace solid-phase microextraction and isotopic dilution. J Chrom A. 2001; 915: 209–216
   PubMed Web of Science ®Google Scholar
• Liu Y, Hua CO. Establishment of a knowledge base for identification of residual solvents in pharmaceuticals. Anal Chim Acta. 2006; 575: 246–254
   PubMed Web of Science ®Google Scholar
• Heidi CM, Alan BF, Elizabeth FS. Patch Testing in an aged population without dermatitis: high prevalence of patch test positivity. Amer J Contact Dermat. 1996; 17(3)155–157
   Google Scholar
• Carlin CS, Feldman SR. A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis. J Am Acad Dermatol. 2004; 50(6)859–866
   PubMed Web of Science ®Google Scholar
• Ehrlich A, Booher S, Becerra Y, et al. Micellar paclitaxel improves severe psoriasis in a prospective phase II pilot study. J Am Acad Dermatol. 2004; 50(4)533–540
   PubMed Web of Science ®Google Scholar
• Chaudhari U, Romano P, Mulcahy LD, et al. Efficacy and safety of Infliximab monotherapy for plaque-type psoriasis: a randomized trial. The Lancet. 2001; 357: 1842–1847
   PubMed Web of Science ®Google Scholar
• Sriram V, Rhodes CT. Preparation and characterization of liposomes as therapeutic delivery systems: a review. Pharma Acta Helv. 1995; 70: 95–111
   PubMedGoogle Scholar
• Vanaja K, Shobha Rani RH. Preformulation study of methotrexate to assess its suitability in transdermal drug delivery. Int J Pharm Excip. 2006, July–Sept: 91
   Google Scholar
• Honeywell-Nguyen LP, Bouwstra JA. The in vitro transport of pergolide from surfactant-based elastic vesicles through human skin: a suggested mechanism of action. J Control Rel. 2003; 86: 145–156
   PubMed Web of Science ®Google Scholar